Polymeric oligopeptide-modified pBAE nanoparticles, anisamide-functionalized for tumor selectivity, protect and deliver mTOR siRNA with serum stability, achieving specific NSCLC knockdown and antitumor efficacy in vitro and in vivo [26]. Here, MTOR is linked to non-small cell lung carcinoma.